209 filings
8-K
INMB
INmune Bio Inc
22 Apr 24
Entry into a Material Definitive Agreement
5:10pm
8-K
INMB
INmune Bio Inc
9 Apr 24
INmune Bio Inc. Presents Data on INB03’s Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024
4:58pm
8-K
INMB
INmune Bio Inc
29 Mar 24
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update
4:01pm
8-K
INMB
INmune Bio Inc
27 Mar 24
INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28
4:07pm
8-K
INMB
INmune Bio Inc
30 Jan 24
INmune Bio Announces FDA Removal of Clinical Hold for Alzheimer’s Disease Program
8:02am
8-K
dgwsqzxddqo8g edat
2 Jan 24
INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer
4:00pm
8-K
t4211f8stfup5sw87sf
18 Dec 23
INmune Bio Provides Update Regarding Global Alzheimer’s Phase II Clinical Trial and Clinical Hold Issued by the United States FDA
4:15pm
8-K
gov 07hoq5adl310f4cz
18 Dec 23
Entry into a Material Definitive Agreement
4:01pm
8-K
mpsw0n73zr0va38 2gp
29 Nov 23
Other Events
4:00pm
8-K
6mepxj4 uk
27 Nov 23
INmune Bio Receives EMA’s Authorization in France and Spain for Phase II Clinical Trial of XPro™ for Early Alzheimer’s Disease
4:00pm
8-K
bvq965iyy3gi
15 Nov 23
INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe
4:13pm
8-K
o24fam hev2u
1 Nov 23
INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update
4:13pm
8-K
cp4pfvm1 4s02at02xc
31 Oct 23
Regulation FD Disclosure
4:25pm
8-K
ai1wz
17 Oct 23
INmune Bio Inc. to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on Wednesday, November 1
7:03pm
8-K
yu02aj44f rts
7 Sep 23
INmune Bio Inc. to Present at Baird Global Healthcare Conference and H.C Wainwright 25th Annual Global Investment Conference
9:10am
8-K
dxkez mvl
5 Sep 23
Other Events
4:00pm
8-K
gg384wme2c99ubq77
16 Aug 23
Entry into a Material Definitive Agreement
4:41pm
8-K
hct0 vw9blayi
8 Aug 23
INmune Bio Inc. Announces Second Quarter 2023 Results and Provides Business Update
4:01pm
8-K
5ks6a5v160yf9w
2 Aug 23
INmune Bio Inc. to Present at the BTIG Virtual Biotechnology Conference
6:02am
8-K
0ak9iz9rs h7s
31 Jul 23
INmune Bio, Inc. to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on Monday, August 7
6:02pm